HSDT
Solana Co
NASDAQ · Healthcare · Medical - Devices · US
$2.24
+0.00%Price chart
Sep 18Sep 23Sep 28Oct 1Oct 6Oct 9Oct 14Oct 19
Key dataOct 19, 2026
Open$2.29
From 52W high−71.13%
Volume411567.00
Market cap$145.83M
P/E (TTM)—
P/S (TTM)12.1x
Div yield—
Key dataOct 19, 2026
Open
$2.29
From 52W high
−71.13%
Volume
411567.00
Market cap
$145.83M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−1.1x
P/E (TTM)
—
RSI (14)
42.1
MomentumView details →
1D Return
+0.00%
YTD Return
−22.11%
SummaryUpdated Jun 1, 2026
Helius Medical Technologies, Inc. (NASDAQ:HSDT) is a neurotechnology company founded in 2014 and headquartered in Newtown, Pennsylvania. The company specializes in developing non-invasive medical devices for treating neurological conditions, with its flagship product being the Portable Neuromodulation Stimulator (PoNS). Since going public in 2014, Helius has focused on commercializing its neurostimulation technology for patients suffering from balance and gait deficits caused by multiple sclerosis, traumatic brain injury, and stroke.
Similar companies
Latest newsMore news →
Samsung C&T Corp. announced USDC transfers in Samsung C&T Corp. Wallet for eligible U.S. Galaxy users, with access planned to begin in the final week of October 2026.5d agoSolana Co plans to activate its Alpenglow network upgrade on October 21, replacing TowerBFT with a consensus mechanism targeting transaction finality of about 150 milliseconds.6d agoSamsung Electronics Co., Ltd. announced that Samsung Electronics Co., Ltd. Wallet will support USDC transfers for eligible US Galaxy devices in the United States, with availability planned for the last week of October 2026.12d ago